Alto Neuroscience, Inc. Common Stock (ANRO)
SG&A Expense Growth
2.59%
Quarterly · Period ending:
ANRO SG&A Expense Growth
Latest reported2.59%period ending
Latest reported2.59%period ending
ANRO Quarterly SG&A Growth (QoQ) (0.00% → 2.59%)
Latest values, visible window
High-resolution chart · PNG
ANRO sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 2.5862% | |
| 35.2837% | |
| 14.3019% | |
| -20.367% | |
| -2.5254% | |
| -5.3924% | |
| 3.4501% | |
| 12.9727% | |
| 18.9071% | |
| 113.6454% | |
| 15.9337% | |
| -10.3431% | |
| 29.6813% | |
| -8.1147% | |
| 0% |